| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Amyotrophic Lateral Sclerosis Associated with Statin Use: A Disproportionality Analysis of the FDA’s Adverse Event Reporting System
|
Golomb, Beatrice A.
|
|
2018
|
41 |
4 |
p. 403-413
|
article
|
| 2 |
Analysis of Spontaneous Postmarket Case Reports Submitted to the FDA Regarding Thromboembolic Adverse Events and JAK Inhibitors
|
Verden, Abril
|
|
2017
|
41 |
4 |
p. 357-361
|
article
|
| 3 |
An Automated System Combining Safety Signal Detection and Prioritization from Healthcare Databases: A Pilot Study
|
Arnaud, Mickael
|
|
2017
|
41 |
4 |
p. 377-387
|
article
|
| 4 |
Beta-Blocker Use in Pregnancy and Risk of Specific Congenital Anomalies: A European Case-Malformed Control Study
|
Bergman, Jorieke E. H.
|
|
2017
|
41 |
4 |
p. 415-427
|
article
|
| 5 |
Cardiovascular Profile of Valbenazine: Analysis of Pooled Data from Three Randomized, Double-Blind, Placebo-Controlled Trials
|
Thai-Cuarto, Dao
|
|
2017
|
41 |
4 |
p. 429-440
|
article
|
| 6 |
Management Strategies to Facilitate Optimal Outcomes for Patients Treated with Delayed-release Dimethyl Fumarate
|
Mayer, Lori
|
|
2017
|
41 |
4 |
p. 347-356
|
article
|
| 7 |
Mixed Approach Retrospective Analyses of Suicide and Suicidal Ideation for Brand Compared with Generic Central Nervous System Drugs
|
Cheng, Ning
|
|
2017
|
41 |
4 |
p. 363-376
|
article
|
| 8 |
Safety of Human Papillomavirus Vaccines: An Updated Review
|
Phillips, Anastasia
|
|
2017
|
41 |
4 |
p. 329-346
|
article
|
| 9 |
The RIMES Statement: A Checklist to Assess the Quality of Studies Evaluating Risk Minimization Programs for Medicinal Products
|
Smith, Meredith Y.
|
|
2017
|
41 |
4 |
p. 389-401
|
article
|
| 10 |
The Safety of Generic Prescription Drugs in the United States
|
Singh, Sonal
|
|
2018
|
41 |
4 |
p. 325-328
|
article
|
Journal description